ALEXANDRIA REAL ESTATE EQUITIES, INC. - 11 Dec 2025 SCHEDULE 13G/A Report for Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT)

Filing Manager
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Reporting Manager
Alexandria Real Estate Equities, Inc.
Security
Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
APLT
Shares outstanding
151,162,791 shares
Disclosed Ownership
6,500,000 shares
Ownership
4.3%
Form type
SCHEDULE 13G/A
Filing time
15 Dec 2025, 17:38:09 UTC
Date of event
11 Dec 2025
SEC
View on sec.gov

Quoteable Key Fact

"ALEXANDRIA REAL ESTATE EQUITIES, INC. disclosed 4.3% ownership in Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT) on 11 Dec 2025."

Quick Takeaways

  • ALEXANDRIA REAL ESTATE EQUITIES, INC. filed SCHEDULE 13G/A for Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT).
  • Disclosed ownership: 4.3%.
  • Date of event: 11 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 Dec 2025, 17:38.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Alexandria Real Estate Equities, Inc. 4.3% 6,500,000 0 6,500,000 /s/ Marc E. Binda By Marc E. Binda, Chief Financial Officer and Treasurer
Alexandria Venture Investments, LLC 3% 4,450,000 0 4,450,000 /s/ Marc E. Binda By Alexandria Real Estate Equities, Inc., managing member, By Marc E. Binda, Chief Financial Officer and Treasurer
Alexandria Equities No. 7, LLC 1.4% 2,050,000 0 2,050,000 /s/ Marc E. Binda See Note 1